192 related articles for article (PubMed ID: 20505882)
21. Establishment and characterization of new cellular lymphoma model expressing transgenic human MDR1.
Findling-Kagan S; Sivan H; Ostrovsky O; Nagler A; Galski H
Leuk Res; 2005 Apr; 29(4):407-14. PubMed ID: 15725475
[TBL] [Abstract][Full Text] [Related]
22. Reversal of multidrug resistance by two nordihydroguaiaretic acid derivatives, M4N and maltose-M3N, and their use in combination with doxorubicin or paclitaxel.
Chang CC; Liang YC; Klutz A; Hsu CI; Lin CF; Mold DE; Chou TC; Lee YC; Huang RC
Cancer Chemother Pharmacol; 2006 Nov; 58(5):640-53. PubMed ID: 16544145
[TBL] [Abstract][Full Text] [Related]
23. Downregulation of JNK/SAPK activity is associated with the cross-resistance to P-glycoprotein-unrelated drugs in multidrug-resistant FM3A/M cells overexpressing P-glycoprotein.
Kang CD; Ahn BK; Jeong CS; Kim KW; Lee HJ; Yoo SD; Chung BS; Kim SH
Exp Cell Res; 2000 Apr; 256(1):300-7. PubMed ID: 10739677
[TBL] [Abstract][Full Text] [Related]
24. Utility of unbound plasma drug levels and P-glycoprotein transport data in prediction of central nervous system exposure.
He H; Lyons KA; Shen X; Yao Z; Bleasby K; Chan G; Hafey M; Li X; Xu S; Salituro GM; Cohen LH; Tang W
Xenobiotica; 2009 Sep; 39(9):687-93. PubMed ID: 19569734
[TBL] [Abstract][Full Text] [Related]
25. Analysis of random recombination between human MDR1 and mouse mdr1a cDNA in a pHaMDR-dihydrofolate reductase bicistronic expression system.
Shoshani T; Zhang S; Dey S; Pastan I; Gottesman MM
Mol Pharmacol; 1998 Oct; 54(4):623-30. PubMed ID: 9765504
[TBL] [Abstract][Full Text] [Related]
26. Characterization of a novel 99mTc-carbonyl complex as a functional probe of MDR1 P-glycoprotein transport activity.
Dyszlewski M; Blake HM; Dahlheimer JL; Pica CM; Piwnica-Worms D
Mol Imaging; 2002; 1(1):24-35. PubMed ID: 12920858
[TBL] [Abstract][Full Text] [Related]
27. In vivo and in vitro multitracer analyses of P-glycoprotein expression-related multidrug resistance.
Márián T; Szabó G; Goda K; Nagy H; Szincsák N; Juhász I; Galuska L; Balkay L; Mikecz P; Trón L; Krasznai Z
Eur J Nucl Med Mol Imaging; 2003 Aug; 30(8):1147-54. PubMed ID: 12830325
[TBL] [Abstract][Full Text] [Related]
28. (67/68)Galmydar: A metalloprobe for monitoring breast cancer resistance protein (BCRP)-mediated functional transport activity.
Sivapackiam J; Harpstrite SE; Prior JL; Mattingly S; Sharma V
Nucl Med Biol; 2016 Mar; 43(3):191-7. PubMed ID: 26924499
[TBL] [Abstract][Full Text] [Related]
29. Interrogation of multidrug resistance (MDR1) P-glycoprotein (ABCB1) expression in human pancreatic carcinoma cells: correlation of 99mTc-Sestamibi uptake with western blot analysis.
Harpstrite SE; Gu H; Natarajan R; Sharma V
Nucl Med Commun; 2014 Oct; 35(10):1067-70. PubMed ID: 25036383
[TBL] [Abstract][Full Text] [Related]
30. 3'-O, 4'-O-aromatic acyl substituted 7,8-pyranocoumarins: a new class of P-glycoprotein modulators.
Shen X; Chen G; Zhu G; Cai J; Wang L; Hu Y; Fong WF
J Pharm Pharmacol; 2012 Jan; 64(1):90-100. PubMed ID: 22150676
[TBL] [Abstract][Full Text] [Related]
31. Probing multidrug resistance P-glycoprotein transporter activity with SPECT radiopharmaceuticals.
Piwnica-Worms D; Sharma V
Curr Top Med Chem; 2010; 10(17):1834-45. PubMed ID: 20645914
[TBL] [Abstract][Full Text] [Related]
32. Antisense targeting of p-glycoprotein expression in tissue culture.
Nakamura K; Kubo A; Hnatowich DJ
J Nucl Med; 2005 Mar; 46(3):509-13. PubMed ID: 15750166
[TBL] [Abstract][Full Text] [Related]
33. Single photon emission computed tomography and positron emission tomography imaging of multi-drug resistant P-glycoprotein--monitoring a transport activity important in cancer, blood-brain barrier function and Alzheimer's disease.
Piwnica-Worms D; Kesarwala AH; Pichler A; Prior JL; Sharma V
Neuroimaging Clin N Am; 2006 Nov; 16(4):575-89, viii. PubMed ID: 17148020
[TBL] [Abstract][Full Text] [Related]
34. Molecular Imaging of P-glycoprotein in Chemoresistant Tumors Using a Dual-Modality PET/Fluorescence Probe.
Wang M; Mao C; Wang H; Ling X; Wu Z; Li Z; Ming X
Mol Pharm; 2017 Oct; 14(10):3391-3398. PubMed ID: 28813596
[TBL] [Abstract][Full Text] [Related]
35. Detection of the MDR1 P-glycoprotein expression and function.
Mechetner E
Methods Mol Biol; 2007; 378():175-93. PubMed ID: 18605086
[TBL] [Abstract][Full Text] [Related]
36. P-glycoprotein (ABCB1) interacts directly with lipid-based anti-cancer drugs and platelet-activating factors.
Eckford PD; Sharom FJ
Biochem Cell Biol; 2006 Dec; 84(6):1022-33. PubMed ID: 17215888
[TBL] [Abstract][Full Text] [Related]
37. Synthesis, characterization, and molecular structure of a novel zinc (II) complex: assessment of impact of MDR1Pgp expression on its cytotoxic activity.
Harpstrite SE; Prior JL; Sivapackiam J; Collins SD; Rath NP; Sharma V
Med Chem; 2010 Jul; 6(4):191-9. PubMed ID: 20843281
[TBL] [Abstract][Full Text] [Related]
38. Radiosynthesis and biological evaluation of 68Ga-labeled colchicine conjugates.
Satpati D; Korde A; Sarma HD; Banerjee S
Cancer Biother Radiopharm; 2014 Aug; 29(6):251-6. PubMed ID: 24983126
[TBL] [Abstract][Full Text] [Related]
39. Choroid plexus epithelial expression of MDR1 P glycoprotein and multidrug resistance-associated protein contribute to the blood-cerebrospinal-fluid drug-permeability barrier.
Rao VV; Dahlheimer JL; Bardgett ME; Snyder AZ; Finch RA; Sartorelli AC; Piwnica-Worms D
Proc Natl Acad Sci U S A; 1999 Mar; 96(7):3900-5. PubMed ID: 10097135
[TBL] [Abstract][Full Text] [Related]
40. In vitro transport profile of carbamazepine, oxcarbazepine, eslicarbazepine acetate, and their active metabolites by human P-glycoprotein.
Zhang C; Zuo Z; Kwan P; Baum L
Epilepsia; 2011 Oct; 52(10):1894-904. PubMed ID: 21692796
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
